2017
DOI: 10.1007/s12350-017-1070-1
|View full text |Cite
|
Sign up to set email alerts
|

ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0
2

Year Published

2019
2019
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(28 citation statements)
references
References 36 publications
0
26
0
2
Order By: Relevance
“…The recent ASE/EACVI consensus defined a relative decrease in GLS of >15% from baseline as an indicator of subclinical LV dysfunction and appropriate use criteria for multi-modality imaging include strain for the evaluation of patient candidates for chemotherapy (19,70). Finally, the SUCCOUR trial (first randomized controlled trial of GLS-guided therapy introduction) will better define the role of GLS for surveillance for chemotherapy-related cardiac dysfunction (71).…”
Section: Tissue Doppler and Strain Echocardiographymentioning
confidence: 99%
“…The recent ASE/EACVI consensus defined a relative decrease in GLS of >15% from baseline as an indicator of subclinical LV dysfunction and appropriate use criteria for multi-modality imaging include strain for the evaluation of patient candidates for chemotherapy (19,70). Finally, the SUCCOUR trial (first randomized controlled trial of GLS-guided therapy introduction) will better define the role of GLS for surveillance for chemotherapy-related cardiac dysfunction (71).…”
Section: Tissue Doppler and Strain Echocardiographymentioning
confidence: 99%
“…The ESC and AHA/ACC guidelines for the management of valvular heart disease emphasize the severity of the MR in deciding whether patients are eligible for mitral valve surgery 3,5 , while also emphasizing the importance of assessing the haemodynamic effects of the MR on the left ventricle and left atrium. The AHA/ACC guidelines highlight that CMR is an appropriate test in chronic primary MR to assess ventricular volumes and function or even MR severity, especially when these issues are not satisfactorily addressed by transthoracic echocardiography (TTE) 5 . In addition, for chronic secondary MR, CMR is indicated to establish and/or to assess myocardial viability, which in turn might influence the management of functional MR 5 .…”
Section: Current Clinical Guidelinesmentioning
confidence: 99%
“…The AHA/ACC guidelines highlight that CMR is an appropriate test in chronic primary MR to assess ventricular volumes and function or even MR severity, especially when these issues are not satisfactorily addressed by transthoracic echocardiography (TTE) 5 . In addition, for chronic secondary MR, CMR is indicated to establish and/or to assess myocardial viability, which in turn might influence the management of functional MR 5 . Similarly, the ESC guidelines on valvular heart disease recommend CMR assessment in patients with inadequate TTE imaging for ventricular volume and function assessment 3 .…”
Section: Current Clinical Guidelinesmentioning
confidence: 99%
See 1 more Smart Citation
“…It is very important to obtain reliable diagnostic and prognostic tools for early and better evaluation of CVD [1][2][3]. Myocardial perfusion imaging (MPI) using single photon emission computed tomography (SPECT) gamma camera has been widely utilized for the diagnosis and risk stratification of IHD [4]. However, the attenuation of gamma rays by the patient's body negatively affects the scintigraphic images in SPECT and produces inhomogeneous defects that decrease the accuracy of the test [5].…”
Section: Introductionmentioning
confidence: 99%